EUVIMEDEUVIMED entdecken
LeserbriefKohortenstudieOpen Access · CC BY 4.0

Epidemiology and Comorbidities of Mucous Membrane Pemphigoid: A National Cohort Study

Päivi Leisti, Laura Huilaja, Jari Jokelainen, Outi Varpuluoma, Kaisa Tasanen

Journal of Investigative Dermatology · 2024

DOI: 10.1016/j.jid.2024.02.008 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Investigative Dermatology, 2024. Verfasst von Päivi Leisti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Research Unit of Clinical Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, F…. Hauptthemen laut MEDLINE: Pemphigoid, Benign Mucous Membrane, Comorbidity. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Finnish Dermatological Society, Academy of Finland, Sigrid Jusélius Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucous membrane pemphigoid (MMP) is a chronic, progressive, and often scarring sub-epidermal autoimmune blistering disease predominantly affecting mucous membranes. Autoantibodies in MMP target multiple antigens including BP180, BP230, laminin 332, collagen VII, and the integrin α6 and β4 subunits (Rashid et al., 2021). The incidence of MMP has been estimated varying from 1.3 to 2.0/million/year. It is more common in females and usually diagnosed between 60 and 80 years of age (Du et al., 2022).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pemphigoid, Benign Mucous MembraneComorbidityHumansFemaleMaleAgedMiddle AgedCohort StudiesAged, 80 and overAdult

Stichwörter der Autor:innen

AutoimmunityBlistering diseaseBullous diseaseComorbiditiesEpidemiologyMucous membrane pemphigoid

Autor:innen und Institutionen

  • Department of Dermatology, Research Unit of Clinical Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Infrastructure for Population Studies, Faculty of Medicine, University of Oulu, Oulu, Finland.
  • Department of Dermatology, Research Unit of Clinical Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland. Electronic address: kaisa.tasanen@oulu.fi.

Förderung

  • Finnish Dermatological Society
  • Academy of Finland
  • Sigrid Jusélius Foundation
  • Oulu University Hospital

Zitieren

APA

Leisti, P., Huilaja, L., Jokelainen, J., Varpuluoma, O., & Tasanen, K. (2024). Epidemiology and Comorbidities of Mucous Membrane Pemphigoid: A National Cohort Study. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2024.02.008

Vancouver

Leisti P, Huilaja L, Jokelainen J, Varpuluoma O, Tasanen K. Epidemiology and Comorbidities of Mucous Membrane Pemphigoid: A National Cohort Study. Journal of Investigative Dermatology. 2024. doi:10.1016/j.jid.2024.02.008

BibTeX
@article{Leisti2024,
  author = {Leisti, Päivi and Huilaja, Laura and Jokelainen, Jari and Varpuluoma, Outi and Tasanen, Kaisa},
  title = {Epidemiology and Comorbidities of Mucous Membrane Pemphigoid: A National Cohort Study},
  journal = {Journal of Investigative Dermatology},
  year = {2024},
  doi = {10.1016/j.jid.2024.02.008}
}
Kostenlos starten →